home / stock / pclof / pclof quote
Last: | $0.128 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1298 |
Close: | $0.128 |
High: | $0.1298 |
Low: | $0.1259 |
Volume: | 9,323 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.128 | $0.1298 | $0.128 | $0.1298 | $0.1259 | 9,323 | 04-18-2024 |
$0.13925 | $0.135 | $0.13925 | $0.13925 | $0.135 | 6,195 | 04-16-2024 |
$0.135 | $0.1475 | $0.135 | $0.1475 | $0.135 | 887 | 04-15-2024 |
$0.159 | $0.1802 | $0.159 | $0.1802 | $0.159 | 2,000 | 04-12-2024 |
$0.178 | $0.158 | $0.178 | $0.1811 | $0.158 | 10,868 | 04-11-2024 |
$0.17715 | $0.17715 | $0.17715 | $0.17715 | $0.17715 | 2,500 | 04-10-2024 |
$0.19415 | $0.19415 | $0.19415 | $0.19415 | $0.19415 | 10,000 | 04-09-2024 |
$0.184 | $0.184 | $0.184 | $0.184 | $0.184 | 1,650 | 04-08-2024 |
$0.192525 | $0.1948 | $0.192525 | $0.1948 | $0.192525 | 400 | 04-05-2024 |
$0.20555 | $0.17955 | $0.20555 | $0.20815 | $0.17955 | 23,626 | 04-04-2024 |
$0.1711 | $0.169056 | $0.1711 | $0.184 | $0.169056 | 11,631 | 04-03-2024 |
$0.1679 | $0.16905 | $0.1679 | $0.1764 | $0.1679 | 9,000 | 04-02-2024 |
$0.14845 | $0.169 | $0.14845 | $0.169 | $0.1351 | 8,852 | 04-01-2024 |
$0.1705 | $0.15005 | $0.1705 | $0.1705 | $0.135 | 18,102 | 03-29-2024 |
$0.1705 | $0.15005 | $0.1705 | $0.1705 | $0.135 | 18,102 | 03-28-2024 |
$0.1545 | $0.141 | $0.1545 | $0.1554 | $0.141 | 4,677 | 03-27-2024 |
$0.153 | $0.13157 | $0.153 | $0.1554 | $0.13095 | 7,219 | 03-26-2024 |
$0.12735 | $0.121 | $0.12735 | $0.13 | $0.121 | 3,221 | 03-25-2024 |
$0.12635 | $0.116 | $0.12635 | $0.13 | $0.111 | 23,153 | 03-22-2024 |
$0.113 | $0.1064 | $0.113 | $0.113 | $0.10635 | 59,403 | 03-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
PharmaCielo Ltd. Company Name:
PCLOF Stock Symbol:
OTCMKTS Market:
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX:PCLOF) revealed its plans to acquire cannabis operations in Thailand. What Happened On Wednesday, the Canadian ...
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...
2024-03-27 17:08:02 ET CEO of PharmaCielo, David Attard speaks to shareholders about the short seller report In early March, Hindenburg Research issued a short seller report targeting PharmaCielo's credibility and its stock. Moreover, the Company believes that this report represen...